collection
MENU ▼
Read by QxMD icon Read
search

New opportunities in hxfx / transplantation

shared collection
10 papers 0 to 25 followers
By Javier Castro Heart Failure And Heart Transplantation
https://www.readbyqxmd.com/read/27364989/natural-history-of-dilated-cardiomyopathy-in-children
#1
Ilaria Puggia, Marco Merlo, Giulia Barbati, Teisha J Rowland, Davide Stolfo, Marta Gigli, Federica Ramani, Andrea Di Lenarda, Luisa Mestroni, Gianfranco Sinagra
BACKGROUND: The long-term progression of idiopathic dilated cardiomyopathy (DCM) in pediatric patients compared with adult patients has not been previously characterized. In this study, we compared outcome and long-term progression of pediatric and adult DCM populations. METHODS AND RESULTS: Between 1988 and 2014, 927 DCM patients were consecutively enrolled. The pediatric population (aged <18 years at enrollment) included 47 participants (5.1%). At presentation, the pediatric population compared with adult patients had a significantly increased occurrence of familial forms (P=0...
June 30, 2016: Journal of the American Heart Association
https://www.readbyqxmd.com/read/26883434/the-fibrosis-cell-death-axis-in-heart-failure
#2
A Piek, R A de Boer, H H W Silljé
Cardiac stress can induce morphological, structural and functional changes of the heart, referred to as cardiac remodeling. Myocardial infarction or sustained overload as a result of pathological causes such as hypertension or valve insufficiency may result in progressive remodeling and finally lead to heart failure (HF). Whereas pathological and physiological (exercise, pregnancy) overload both stimulate cardiomyocyte growth (hypertrophy), only pathological remodeling is characterized by increased deposition of extracellular matrix proteins, termed fibrosis, and loss of cardiomyocytes by necrosis, apoptosis and/or phagocytosis...
March 2016: Heart Failure Reviews
https://www.readbyqxmd.com/read/26794635/fingerprints-of-transplant-tolerance-suggest-opportunities-for-immunosuppression-minimization
#3
Minnie M Sarwal
HLA incompatible organ transplant tolerance is the holy grail of transplantation. Stable engraftment of an HLA mismatched allograft and life-long tolerance induction, though feasible in highly selected cohorts with depletional protocols, is not ready for generalized application to the entire transplant recipient pool. It has thus been important to harness biomarkers that can uncover mechanisms and tools for monitoring HLA mismatched recipients that develop a state of operational tolerance, during accidental immunosuppression withdrawal secondary to problems of over-immunosuppression (infection or malignancy) or toxicity (mostly cosmetic or cardiovascular)...
March 2016: Clinical Biochemistry
https://www.readbyqxmd.com/read/26663613/elevated-st2-distinguishes-incidences-of-pediatric-heart-and-small-bowel-transplant-rejection
#4
L R Mathews, J M Lott, K Isse, A Lesniak, D Landsittel, A J Demetris, Y Sun, D F Mercer, S A Webber, A Zeevi, R T Fischer, B Feingold, H R Turnquist
Elevated serum soluble (s) suppressor of tumorigenicity-2 is observed during cardiovascular and inflammatory bowel diseases. To ascertain whether modulated ST2 levels signify heart (HTx) or small bowel transplant (SBTx) rejection, we quantified sST2 in serially obtained pediatric HTx (n = 41) and SBTx recipient (n = 18) sera. At times of biopsy-diagnosed HTx rejection (cellular and/or antibody-mediated), serum sST2 was elevated compared to rejection-free time points (1714 ± 329 vs. 546.5 ± 141.6 pg/mL; p = 0...
March 2016: American Journal of Transplantation
https://www.readbyqxmd.com/read/26262459/current-indications-strategies-and-outcomes-with-cardiac-transplantation-for-cardiac-amyloidosis-and-sarcoidosis
#5
REVIEW
Andrew N Rosenbaum, Brooks S Edwards
PURPOSE OF REVIEW: We describe the general strategies for the management of cardiac amyloidosis with particular focus on the use of cardiac transplantation for amyloid cardiomyopathy. Within this article, we highlight recent data regarding the use of combined heart transplant-chemotherapy, use of cardiac transplant in mutant amyloid disease, and underutilization of cardiac transplantation in sarcoidosis. RECENT FINDINGS: Several center experiences have been recently published, describing management strategies in AL amyloid, with focus on timing of chemotherapy as it relates to transplant, and in mutant amyloid in particular...
October 2015: Current Opinion in Organ Transplantation
https://www.readbyqxmd.com/read/26215768/effect-of-tadalafil-on-myocardial-and-endothelial-function-and-exercise-performance-after-modified-fontan-operation
#6
Mohammad-Reza Sabri, Ali Zolfi-Gol, Alireza Ahmadi, Shaghayegh Haghjooy-Javanmard
Better postoperative management of patients who have undergone single ventricle (SV) Fontan procedure could potentially reduce long-term complications and improve the quality of life for patients. The present study determined the effect of tadalafil on myocardial and endothelial function and exercise performance after modified Fontan operation. Patients who had undergone SV modified Fontan operation were enrolled in this clinical trial. The demographic characteristics of the patients were recorded. Before administration of tadalafil and after the trial, ventricular function (MPI, EF, FS, E/A, VTI), exercise performance, and endothelial function were evaluated for sonographic and biochemical markers (FMD, IMT, ICAM, VCAM, NO) using echocardiography, exercise testing, vascular ultrasonography, and biochemical measurements, respectively...
January 2016: Pediatric Cardiology
https://www.readbyqxmd.com/read/26232891/international-normalized-ratio-variability-a-measure-of-anticoagulation-quality-or-a-powerful-mortality-predictor
#7
Gabriel Vanerio
BACKGROUND: As atrial fibrillation (AF) carries twice the mortality hazard when compared with a similar population without diagnosed AF, the importance of risk stratifying is obvious. Several variables are related to outcome: age, comorbidities, and use of several medications, particularly oral anticoagulants. The CHA2DS2VASc score is an extremely useful tool to predict thromboembolic events and also mortality. The international normalized ratio (INR) variability is a treatment efficacy variable also associated with morbidity in patients receiving warfarin...
October 2015: Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association
https://www.readbyqxmd.com/read/26234792/role-of-antioxidants-for-the-treatment-of-cardiovascular-diseases-challenges-and-opportunities
#8
REVIEW
Amit K Jain, Neelesh K Mehra, Nitin K Swarnakar
Cardiovascular disorders or cardiovascular diseases (CVD) are major illness associated with heart and blood vessels. Reactive oxygen species (ROS), generated during excessive oxidative stress, are responsible for the pathophysiology of various cardiovascular disorders including atherosclerosis, cardiac hypertrophy, cardiomyopathy, heart failure, ventricular remodeling, ischemia/reperfusion injury and myocardial infarction. Cellular "redox homeostasis" generally maintains the healthy physiology in cardiac myocytes and endothelial cells...
2015: Current Pharmaceutical Design
https://www.readbyqxmd.com/read/26236569/new-drugs-you-are-going-to-read-about-serelaxin-ularitide-trv027
#9
Vijaya Arun Kumar, David Viau, Phillip Levy
Nitrovasodilators have long been used as first-line treatment for hypertensive acute heart failure (AHF). Although effective for BP control and symptom alleviation, this class of agents has never been shown to improve mortality or prevent hospital readmissions. Consequently, there has been tremendous interest in development of newer vasodilators with more beneficial therapeutic profiles. In this review, we focus on three of the most promising agents currently being studied: serelaxin, ularitide, and TRV027...
May 1, 2015: Current Emergency and Hospital Medicine Reports
https://www.readbyqxmd.com/read/26236717/animal-models-and-omics-technologies-for-identification-of-novel-biomarkers-and-drug-targets-to-prevent-heart-failure
#10
REVIEW
Yunlong Hou, Juan M Adrian-Segarra, Manfred Richter, Natalia Kubin, Jaeyoung Shin, Isabella Werner, Thomas Walther, Markus Schönburg, Jochen Pöling, Henning Warnecke, Thomas Braun, Sawa Kostin, Thomas Kubin
It is now accepted that heart failure (HF) is a complex multifunctional disease rather than simply a hemodynamic dysfunction. Despite its complexity, stressed cardiomyocytes often follow conserved patterns of structural remodelling in order to adapt, survive, and regenerate. When cardiac adaptations cannot cope with mechanical, ischemic, and metabolic loads efficiently or become chronically activated, as, for example, after infection, then the ongoing structural remodelling and dedifferentiation often lead to compromised pump function and patient death...
2015: BioMed Research International
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"